A detailed history of Time Scale Financial, Inc. transactions in Gt Biopharma, Inc. stock. As of the latest transaction made, Time Scale Financial, Inc. holds 549 shares of GTBP stock, worth $1,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares
549
Previous 549 -0.0%
Holding current value
$1,608
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021

BUY
$4.4 - $8.84 $2,415 - $4,853
549 New
549 $4,000

Others Institutions Holding GTBP

About GT Biopharma, Inc.


  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $95.4M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Time Scale Financial, Inc. Portfolio

Follow Time Scale Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Time Scale Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Time Scale Financial, Inc. with notifications on news.